Nevertheless, there are exceptions. For instance, flagship indices like the S&P 500 and the Nasdaq-100 remain stalwarts in the industry. Additionally, some niche indices that focus on specific sub-sectors or assets, like the Nasdaq Biotechnology Index, still stand out.
With skirmishes in the so-called fee war in the ETF still ongoing, ETF providers are trying to reduce costs wherever they can. They are becoming more aware of the costs associated with indexing and more willing to look at alternatives. All of this, though, means that the end-users, or investors, will be saving more and focus on potentially greater returns.
For more information on indexing in ETFs, visit our indexing category.
Max Chen contributed to this article.